Automate Your Wheel Strategy on MDXH
With Tiblio's Option Bot, you can configure your own wheel strategy including MDXH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDXH
- Rev/Share 1.8428
- Book/Share 0.3037
- PB 7.3423
- Debt/Equity 4.0472
- CurrentRatio 1.568
- ROIC -0.2252
- MktCap 110379055.0
- FreeCF/Share -0.4398
- PFCF -5.1363
- PE -2.8624
- Debt/Assets 0.3818
- DivYield 0
- ROE -6.9059
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA (MDXH)
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Positive
MDxHealth SA (MDXH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
MDxHealth SA (NASDAQ:MDXH ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants John Fraunces - LifeSci Advisors, IR Michael McGarrity - Chief Executive Officer Ron Kalfus - Chief Financial Officer Conference Call Participants Thomas Flaten - Lake Street Andrew Brackmann - William Blair Thomas Vranken - KBC Securities Jason Bednar - Piper Sandler Vidyun Bais - BTIG Dan Brennan - TD Cowen Operator Good day. And welcome to the MDxHealth Fourth Quarter and Full Year 2024 Earnings Call.
Read More
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Fourth quarter revenue growth of 28% to $24.7 million 2024 revenue growth of 28% to $90.0 million 68% improvement in adjusted EBITDA in fourth quarter Conference call with Q&A today at 4:30 PM EST / 22:30 CET
Read More
About MDxHealth S.A. (MDXH)
- IPO Date 2021-11-04
- Website https://mdxhealth.com
- Industry Medical - Diagnostics & Research
- CEO Michael K. McGarrity
- Employees 312